Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1400737

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1400737

Injectable Drug Delivery Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

PUBLISHED:
PAGES: 307 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The global Injectable Drug Delivery Market is poised for substantial growth, with 2024 revenues reaching approximately US$ 49 billion. A comprehensive market analysis indicates that the market is expected to reach a valuation of approximately US$ 96 billion by the end of 2031.

Understanding Injectable Drug Delivery:

Injectable drug delivery involves administering medications directly into the bloodstream via injection. It is increasingly favored for its effectiveness and reliability in treating various diseases.

Key Market Drivers:

1. Rising Prevalence of Chronic Diseases: The increasing prevalence of chronic diseases, particularly diabetes, is driving the adoption of injectable drug delivery products.

2. Diabetes Epidemic: Diabetes is a major contributor to chronic diseases, and its escalating prevalence is propelling the demand for self-monitoring and diagnosis, leading to greater use of injectable drug delivery products.

3. Growing Demand for Advanced Devices: Patients are seeking novel medication delivery systems that are painless, secure, easy to use, and cost-effective. Advanced devices like insulin pens and pumps are gaining popularity for their advantages over conventional injections.

Factors Driving Growth in Different Regions:

1. United States: The U.S. market is booming due to its large population suffering from chronic diseases. Six out of ten Americans live with chronic conditions such as cancer, heart disease, or diabetes, driving demand for injectable drug delivery products.

2. Germany: Increased research and development related to insulin pens, such as ESYSTA and Pendiq, have made Germany dominant in the European market for injectable drug delivery.

3. China: The rise in the geriatric population in China is a significant factor contributing to the growth of the injectable drug delivery market.

Challenges Impacting Market Growth:

1. High Operational Costs: The manufacturing of injectable drug delivery products involves sophisticated machinery, resulting in high operational costs for companies.

Key Growth Drivers by Region:

1. United States: The vast population suffering from various chronic diseases is driving the country's demand for injectable drug delivery products. According to the CDC, six out of ten Americans live with chronic diseases like cancer, heart disease, or diabetes.

2. Germany: The increased research and development in insulin pens have made Germany dominant in the European market. ESYSTA and Pendiq are two insulin pens developed and marketed by German companies, contributing to market growth.

3. China: China's rising geriatric population is a significant factor contributing to the growth of the injectable drug delivery market.

Competitive Landscape:

Major companies in the market are focused on expanding their product lines and growing in emerging markets. Many are developing novel injectable medication delivery systems, while others are expanding their regional presence or product portfolios through acquisitions.

Key Companies Profiled:

  • Eli Lilly and Company
  • Biocon
  • Becton, Dickinson & Company
  • West Pharmaceutical Services, Inc.
  • Johnson & Johnson
  • Antares Pharma
  • AbbVie Inc.
  • Pfizer Inc.
  • Mylan N.V.
  • Vetter Pharma-Fertigung GmbH & Co.KG
  • Emperra GmbH
  • Digital Medics Pty Ltd
  • Enable Injections LLC
  • Insulet corporation
  • Consort Medical Plc.
  • Diabnext
  • Diamesco Co., Ltd
  • SCHOTT AG (Schott Kaisha Pvt. Ltd.)
  • SiO2 Medical Products
  • Integrity Bio, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Tandem Diabetes Care
  • Sanofi S.A.
  • Companion Medical Inc.
  • Ypsomed
  • F. Hoffman - La Roche Ltd.
  • Novo Nordisk A/S
  • Medtronic Plc.

Market Segmentation

Product:

  • Self-Injectors

Single Chamber Self Injectors

Dual Chamber Self Injectors

  • Needle Free Injectors

Pre Filled Needle Free Injectors

Fill-Able Needle free Injectors

  • Auto Injectors

Prefilled Auto Injectors

Fill-Able Auto Injectors

  • Wearable Injectors

Wearable Patch Injectors

Off-body Worn Injectors

  • Insulin Pens

Reusable Insulin Pens

Disposable Insulin Pens

Smart Insulin Pens

Technology:

  • Non-Smart Injectors
  • Smart Injectors

Artificial Intelligence (AI) and Machine Learning Integrated

Near Filed Communication (NFC)

Cloud Computing

Bluetooth

Usage:

  • Disposable Injectors
  • Reusable Injectors

Indication:

  • Anaphylaxis
  • Diabetes
  • Cardiovascular Diseases
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Cancer
  • Trauma and Emergency
  • Others

Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Online Pharmacies

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa (MEA)
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Injectable Drug Delivery Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Injectable Drug Delivery Market Outlook, 2018 - 2031

  • 3.1. Global Injectable Drug Delivery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Self-Injectors
        • 3.1.1.1.1. Single Chamber Self Injectors
        • 3.1.1.1.2. Dual Chamber Self Injectors
      • 3.1.1.2. Needle Free Injectors
        • 3.1.1.2.1. Pre Filled Needle Free Injectors
        • 3.1.1.2.2. Fill-Able Needle free Injectors
      • 3.1.1.3. Auto Injectors
        • 3.1.1.3.1. Prefilled Auto Injectors
        • 3.1.1.3.2. Market Bytes Companies FAQ
      • 3.1.1.4. Wearable Injectors
        • 3.1.1.4.1. Wearable Patch Injectors
        • 3.1.1.4.2. Off-body Worn Injectors
      • 3.1.1.5. Insulin Pens
        • 3.1.1.5.1. Reusable Insulin Pens
        • 3.1.1.5.2. Disposable Insulin Pens
        • 3.1.1.5.3. Smart Insulin Pens Others
  • 3.2. Global Injectable Drug Delivery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Non-Smart Injectors
      • 3.2.1.2. Smart Injectors
        • 3.2.1.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
        • 3.2.1.2.2. Near Filed Communication (NFC)
        • 3.2.1.2.3. Cloud Computing
        • 3.2.1.2.4. Bluetooth
  • 3.3. Global Injectable Drug Delivery Market Outlook, by Usage, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Disposable Injectors
      • 3.3.1.2. Reusable Injectors
  • 3.4. Global Injectable Drug Delivery Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Anaphylaxis
      • 3.4.1.2. Diabetes
      • 3.4.1.3. Cardiovascular Diseases
      • 3.4.1.4. Multiple Sclerosis
      • 3.4.1.5. Rheumatoid Arthritis
      • 3.4.1.6. Cancer
      • 3.4.1.7. Trauma and Emergency
      • 3.4.1.8. Others
  • 3.5. Others Global Injectable Drug Delivery Market Outlook, by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. Hospital Pharmacies
      • 3.5.1.2. Drug Stores
      • 3.5.1.3. Retail Pharmacies
      • 3.5.1.4. Online Pharmacies
  • 3.6. Global Injectable Drug Delivery Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.6.1. Key Highlights
      • 3.6.1.1. North America
      • 3.6.1.2. Europe
      • 3.6.1.3. Asia Pacific
      • 3.6.1.4. Latin America
      • 3.6.1.5. Middle East & Africa

4. North America Injectable Drug Delivery Market Outlook, 2018 - 2031

  • 4.1. North America Injectable Drug Delivery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Self-Injectors
        • 4.1.1.1.1. Single Chamber Self Injectors
        • 4.1.1.1.2. Dual Chamber Self Injectors
      • 4.1.1.2. Needle Free Injectors
        • 4.1.1.2.1. Pre Filled Needle Free Injectors
        • 4.1.1.2.2. Fill-Able Needle free Injectors
      • 4.1.1.3. Auto Injectors
        • 4.1.1.3.1. Prefilled Auto Injectors
        • 4.1.1.3.2. Market Bytes Companies FAQ
      • 4.1.1.4. Wearable Injectors
        • 4.1.1.4.1. Wearable Patch Injectors
        • 4.1.1.4.2. Off-body Worn Injectors
      • 4.1.1.5. Insulin Pens
        • 4.1.1.5.1. Reusable Insulin Pens
        • 4.1.1.5.2. Disposable Insulin Pens
        • 4.1.1.5.3. Smart Insulin Pens Others
  • 4.2. North America Injectable Drug Delivery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Non-Smart Injectors
      • 4.2.1.2. Smart Injectors
        • 4.2.1.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
        • 4.2.1.2.2. Near Filed Communication (NFC)
        • 4.2.1.2.3. Cloud Computing
        • 4.2.1.2.4. Bluetooth
  • 4.3. North America Injectable Drug Delivery Market Outlook, by Usage, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Disposable Injectors
      • 4.3.1.2. Reusable Injectors
  • 4.4. North America Injectable Drug Delivery Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Anaphylaxis
      • 4.4.1.2. Diabetes
      • 4.4.1.3. Cardiovascular Diseases
      • 4.4.1.4. Multiple Sclerosis
      • 4.4.1.5. Rheumatoid Arthritis
      • 4.4.1.6. Cancer
      • 4.4.1.7. Trauma and Emergency
      • 4.4.1.8. Others
  • 4.5. North America Injectable Drug Delivery Market Outlook, by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. Hospital Pharmacies
      • 4.5.1.2. Drug Stores
      • 4.5.1.3. Retail Pharmacies
      • 4.5.1.4. Online Pharmacies
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis
  • 4.6. North America Injectable Drug Delivery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.6.1. Key Highlights
      • 4.6.1.1. U.S. Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 4.6.1.2. U.S. Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 4.6.1.3. U.S. Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 4.6.1.4. U.S. Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 4.6.1.5. U.S. Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 4.6.1.6. Canada Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 4.6.1.7. Canada Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 4.6.1.8. Canada Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 4.6.1.9. Canada Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 4.6.1.10. Canada Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 4.6.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Injectable Drug Delivery Market Outlook, 2018 - 2031

  • 5.1. Europe Injectable Drug Delivery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Self-Injectors
        • 5.1.1.1.1. Single Chamber Self Injectors
        • 5.1.1.1.2. Dual Chamber Self Injectors
      • 5.1.1.2. Needle Free Injectors
        • 5.1.1.2.1. Pre Filled Needle Free Injectors
        • 5.1.1.2.2. Fill-Able Needle free Injectors
      • 5.1.1.3. Auto Injectors
        • 5.1.1.3.1. Prefilled Auto Injectors
        • 5.1.1.3.2. Market Bytes Companies FAQ
      • 5.1.1.4. Wearable Injectors
        • 5.1.1.4.1. Wearable Patch Injectors
        • 5.1.1.4.2. Off-body Worn Injectors
      • 5.1.1.5. Insulin Pens
        • 5.1.1.5.1. Reusable Insulin Pens
        • 5.1.1.5.2. Disposable Insulin Pens
        • 5.1.1.5.3. Smart Insulin Pens Others
  • 5.2. Europe Injectable Drug Delivery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Non-Smart Injectors
      • 5.2.1.2. Smart Injectors
        • 5.2.1.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
        • 5.2.1.2.2. Near Filed Communication (NFC)
        • 5.2.1.2.3. Cloud Computing
        • 5.2.1.2.4. Bluetooth
  • 5.3. Europe Injectable Drug Delivery Market Outlook, by Usage, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Disposable Injectors
      • 5.3.1.2. Reusable Injectors
  • 5.4. Europe Injectable Drug Delivery Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Anaphylaxis
      • 5.4.1.2. Diabetes
      • 5.4.1.3. Cardiovascular Diseases
      • 5.4.1.4. Multiple Sclerosis
      • 5.4.1.5. Rheumatoid Arthritis
      • 5.4.1.6. Cancer
      • 5.4.1.7. Trauma and Emergency
      • 5.4.1.8. Others
  • 5.5. Europe Injectable Drug Delivery Market Outlook, by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Hospital Pharmacies
      • 5.5.1.2. Drug Stores
      • 5.5.1.3. Retail Pharmacies
      • 5.5.1.4. Online Pharmacies
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis
  • 5.6. Europe Injectable Drug Delivery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.6.1. Key Highlights
      • 5.6.1.1. Germany Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.6.1.2. Germany Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.6.1.3. Germany Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 5.6.1.4. Germany Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.6.1.5. Germany Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 5.6.1.6. U.K. Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.6.1.7. U.K. Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.6.1.8. U.K. Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 5.6.1.9. U.K. Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.6.1.10. U.K. Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 5.6.1.11. France Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.6.1.12. France Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.6.1.13. France Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 5.6.1.14. France Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.6.1.15. France Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 5.6.1.16. Italy Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.6.1.17. Italy Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.6.1.18. Italy Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 5.6.1.19. Italy Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.6.1.20. Italy Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 5.6.1.21. Turkey Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.6.1.22. Turkey Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.6.1.23. Turkey Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 5.6.1.24. Turkey Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.6.1.25. Turkey Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 5.6.1.26. Russia Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.6.1.27. Russia Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.6.1.28. Russia Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 5.6.1.29. Russia Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.6.1.30. Russia Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 5.6.1.31. Rest of Europe Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 5.6.1.32. Rest of Europe Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 5.6.1.33. Rest of Europe Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 5.6.1.34. Rest of Europe Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 5.6.1.35. Rest of Europe Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 5.6.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Injectable Drug Delivery Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Injectable Drug Delivery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Self-Injectors
        • 6.1.1.1.1. Single Chamber Self Injectors
        • 6.1.1.1.2. Dual Chamber Self Injectors
      • 6.1.1.2. Needle Free Injectors
        • 6.1.1.2.1. Pre Filled Needle Free Injectors
        • 6.1.1.2.2. Fill-Able Needle free Injectors
      • 6.1.1.3. Auto Injectors
        • 6.1.1.3.1. Prefilled Auto Injectors
        • 6.1.1.3.2. Market Bytes Companies FAQ
      • 6.1.1.4. Wearable Injectors
        • 6.1.1.4.1. Wearable Patch Injectors
        • 6.1.1.4.2. Off-body Worn Injectors
      • 6.1.1.5. Insulin Pens
        • 6.1.1.5.1. Reusable Insulin Pens
        • 6.1.1.5.2. Disposable Insulin Pens
        • 6.1.1.5.3. Smart Insulin Pens Others
  • 6.2. Asia Pacific Injectable Drug Delivery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Non-Smart Injectors
      • 6.2.1.2. Smart Injectors
        • 6.2.1.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
        • 6.2.1.2.2. Near Filed Communication (NFC)
        • 6.2.1.2.3. Cloud Computing
        • 6.2.1.2.4. Bluetooth
  • 6.3. Asia Pacific Injectable Drug Delivery Market Outlook, by Usage, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Disposable Injectors
      • 6.3.1.2. Reusable Injectors
  • 6.4. Asia Pacific Injectable Drug Delivery Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Anaphylaxis
      • 6.4.1.2. Diabetes
      • 6.4.1.3. Cardiovascular Diseases
      • 6.4.1.4. Multiple Sclerosis
      • 6.4.1.5. Rheumatoid Arthritis
      • 6.4.1.6. Cancer
      • 6.4.1.7. Trauma and Emergency
      • 6.4.1.8. Others
  • 6.5. Asia Pacific Injectable Drug Delivery Market Outlook, by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. Hospital Pharmacies
      • 6.5.1.2. Drug Stores
      • 6.5.1.3. Retail Pharmacies
      • 6.5.1.4. Online Pharmacies
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis
  • 6.6. Asia Pacific Injectable Drug Delivery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.6.1. Key Highlights
      • 6.6.1.1. China Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.6.1.2. China Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.6.1.3. China Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 6.6.1.4. China Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.6.1.5. China Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 6.6.1.6. Japan Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.6.1.7. Japan Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.6.1.8. Japan Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 6.6.1.9. Japan Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.6.1.10. Japan Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 6.6.1.11. South Korea Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.6.1.12. South Korea Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.6.1.13. South Korea Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 6.6.1.14. South Korea Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.6.1.15. South Korea Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 6.6.1.16. India Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.6.1.17. India Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.6.1.18. India Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 6.6.1.19. India Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.6.1.20. India Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 6.6.1.21. Southeast Asia Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.6.1.22. Southeast Asia Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.6.1.23. Southeast Asia Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 6.6.1.24. Southeast Asia Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.6.1.25. Southeast Asia Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 6.6.1.26. Rest of Asia Pacific Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 6.6.1.27. Rest of Asia Pacific Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 6.6.1.28. Rest of Asia Pacific Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 6.6.1.29. Rest of Asia Pacific Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 6.6.1.30. Rest of Asia Pacific Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Injectable Drug Delivery Market Outlook, 2018 - 2031

  • 7.1. Latin America Injectable Drug Delivery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Self-Injectors
        • 7.1.1.1.1. Single Chamber Self Injectors
        • 7.1.1.1.2. Dual Chamber Self Injectors
      • 7.1.1.2. Needle Free Injectors
        • 7.1.1.2.1. Pre Filled Needle Free Injectors
        • 7.1.1.2.2. Fill-Able Needle free Injectors
      • 7.1.1.3. Auto Injectors
        • 7.1.1.3.1. Prefilled Auto Injectors
        • 7.1.1.3.2. Market Bytes Companies FAQ
      • 7.1.1.4. Wearable Injectors
        • 7.1.1.4.1. Wearable Patch Injectors
        • 7.1.1.4.2. Off-body Worn Injectors
      • 7.1.1.5. Insulin Pens
        • 7.1.1.5.1. Reusable Insulin Pens
        • 7.1.1.5.2. Disposable Insulin Pens
        • 7.1.1.5.3. Smart Insulin Pens Others
  • 7.2. Latin America Injectable Drug Delivery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Non-Smart Injectors
      • 7.2.1.2. Smart Injectors
        • 7.2.1.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
        • 7.2.1.2.2. Near Filed Communication (NFC)
        • 7.2.1.2.3. Cloud Computing
        • 7.2.1.2.4. Bluetooth
  • 7.3. Latin America Injectable Drug Delivery Market Outlook, by Usage, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Disposable Injectors
      • 7.3.1.2. Reusable Injectors
  • 7.4. Latin America Injectable Drug Delivery Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Anaphylaxis
      • 7.4.1.2. Diabetes
      • 7.4.1.3. Cardiovascular Diseases
      • 7.4.1.4. Multiple Sclerosis
      • 7.4.1.5. Rheumatoid Arthritis
      • 7.4.1.6. Cancer
      • 7.4.1.7. Trauma and Emergency
      • 7.4.1.8. Others
  • 7.5. Latin America Injectable Drug Delivery Market Outlook, by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Hospital Pharmacies
      • 7.5.1.2. Drug Stores
      • 7.5.1.3. Retail Pharmacies
      • 7.5.1.4. Online Pharmacies
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis
  • 7.6. Latin America Injectable Drug Delivery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.6.1. Key Highlights
      • 7.6.1.1. Brazil Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.6.1.2. Brazil Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.6.1.3. Brazil Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 7.6.1.4. Brazil Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 7.6.1.5. Brazil Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 7.6.1.6. Mexico Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.6.1.7. Mexico Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.6.1.8. Mexico Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 7.6.1.9. Mexico Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 7.6.1.10. Mexico Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 7.6.1.11. Argentina Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.6.1.12. Argentina Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.6.1.13. Argentina Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 7.6.1.14. Argentina Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 7.6.1.15. Argentina Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 7.6.1.16. Rest of Latin America Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 7.6.1.17. Rest of Latin America Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 7.6.1.18. Rest of Latin America Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 7.6.1.19. Rest of Latin America Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 7.6.1.20. Rest of Latin America Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Injectable Drug Delivery Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Injectable Drug Delivery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Self-Injectors
        • 8.1.1.1.1. Single Chamber Self Injectors
        • 8.1.1.1.2. Dual Chamber Self Injectors
      • 8.1.1.2. Needle Free Injectors
        • 8.1.1.2.1. Pre Filled Needle Free Injectors
        • 8.1.1.2.2. Fill-Able Needle free Injectors
      • 8.1.1.3. Auto Injectors
        • 8.1.1.3.1. Prefilled Auto Injectors
        • 8.1.1.3.2. Market Bytes Companies FAQ
      • 8.1.1.4. Wearable Injectors
        • 8.1.1.4.1. Wearable Patch Injectors
        • 8.1.1.4.2. Off-body Worn Injectors
      • 8.1.1.5. Insulin Pens
        • 8.1.1.5.1. Reusable Insulin Pens
        • 8.1.1.5.2. Disposable Insulin Pens
        • 8.1.1.5.3. Smart Insulin Pens Others
  • 8.2. Middle East & Africa Injectable Drug Delivery Market Outlook, by Technology, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Non-Smart Injectors
      • 8.2.1.2. Smart Injectors
        • 8.2.1.2.1. Artificial Intelligence (AI) and Machine Learning Integrated
        • 8.2.1.2.2. Near Filed Communication (NFC)
        • 8.2.1.2.3. Cloud Computing
        • 8.2.1.2.4. Bluetooth
  • 8.3. Middle East & Africa Injectable Drug Delivery Market Outlook, by Usage, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Disposable Injectors
      • 8.3.1.2. Reusable Injectors
  • 8.4. Middle East & Africa Injectable Drug Delivery Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Anaphylaxis
      • 8.4.1.2. Diabetes
      • 8.4.1.3. Cardiovascular Diseases
      • 8.4.1.4. Multiple Sclerosis
      • 8.4.1.5. Rheumatoid Arthritis
      • 8.4.1.6. Cancer
      • 8.4.1.7. Trauma and Emergency
      • 8.4.1.8. Others
  • 8.5. Middle East & Africa Injectable Drug Delivery Market Outlook, by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. Hospital Pharmacies
      • 8.5.1.2. Drug Stores
      • 8.5.1.3. Retail Pharmacies
      • 8.5.1.4. Online Pharmacies
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis
  • 8.6. Middle East & Africa Injectable Drug Delivery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.6.1. Key Highlights
      • 8.6.1.1. GCC Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.6.1.2. GCC Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.6.1.3. GCC Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 8.6.1.4. GCC Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.6.1.5. GCC Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 8.6.1.6. South Africa Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.6.1.7. South Africa Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.6.1.8. South Africa Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 8.6.1.9. South Africa Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.6.1.10. South Africa Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 8.6.1.11. Egypt Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.6.1.12. Egypt Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.6.1.13. Egypt Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 8.6.1.14. Egypt Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.6.1.15. Egypt Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 8.6.1.16. Nigeria Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.6.1.17. Nigeria Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.6.1.18. Nigeria Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 8.6.1.19. Nigeria Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.6.1.20. Nigeria Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
      • 8.6.1.21. Rest of Middle East & Africa Injectable Drug Delivery Market by Product, Value (US$ Bn), 2018 - 2031
      • 8.6.1.22. Rest of Middle East & Africa Injectable Drug Delivery Market by Technology, Value (US$ Bn), 2018 - 2031
      • 8.6.1.23. Rest of Middle East & Africa Injectable Drug Delivery Market by Usage, Value (US$ Bn), 2018 - 2031
      • 8.6.1.24. Rest of Middle East & Africa Injectable Drug Delivery Market by Indication, Value (US$ Bn), 2018 - 2031
      • 8.6.1.25. Rest of Middle East & Africa Injectable Drug Delivery Market by Distribution channel, Value (US$ Bn), 2018 - 2031
    • 8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Species vs by Technology Heat map
  • 9.2. Manufacturer vs by Technology Heat map
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Eli Lilly and Company
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Biocon
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Becton, Dickinson & Company
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. West Pharmaceutical Services, Inc.
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Johnson & Johnson
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Antares Pharma
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. AbbVie Inc
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Pfizer Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Mylan N.V
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Vetter Pharma-Fertigung GmbH & Co.KG
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Emperra GmbH
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Digital Medics Pty Ltd
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Enable Injections LLC
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Insulet corporation
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. Consort Medical Plc
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development
    • 9.5.16. Diabnext
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Product Portfolio
      • 9.5.16.3. Financial Overview
      • 9.5.16.4. Business Strategies and Development
    • 9.5.17. Diamesco Co., Ltd
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Product Portfolio
      • 9.5.17.3. Financial Overview
      • 9.5.17.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!